Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 9, 2018
April 16, 2020
b9156407-8a16-47ed-a9dc-f5ba2ff61852
Related Documents
Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation
Guidance DocumentApril 5, 2018Center for Drug Evaluation and Research
Over-the-Counter Pediatric Oral Liquid Drug Products Containing Acetaminophen
Guidance DocumentAugust 5, 2015Center for Drug Evaluation and Research
Expiration Dating of Unit-Dose Repackaged Solid Oral Dosage Form Drug Products: Guidance for Industry
Guidance DocumentJuly 29, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox